Please use this identifier to cite or link to this item:
http://doi.org/10.25358/openscience-8359
Authors: | Klimek, Ludger Hagemann, Jan Döge, Julia Freudelsperger, Laura Cuevas, Mandy Klimek, Felix Hummel, Thomas |
Title: | Olfactory and gustatory disorders in COVID-19 |
Online publication date: | 5-Jan-2023 |
Year of first publication: | 2022 |
Language: | english |
Abstract: | Loss of olfaction is one of the symptoms most commonly reported by patients with coronavirus disease 2019 (COVID-19). Although the spontaneous recovery rate is high, recent studies have shown that up to 7% of patients remain anosmic for more than 12 months after the onset of infection, leaving millions of people worldwide suffering from severe olfactory impairment. Olfactory training remains the first recommended treatment. With the continued lack of approved drug treatments, new therapeutic options are being explored. This article reviews the current state of science on COVID-19-related olfactory disorders, focusing on epidemiology, pathophysiology, cure rates, currently available treatment options, and research on new treatments. |
DDC: | 610 Medizin 610 Medical sciences |
Institution: | Johannes Gutenberg-Universität Mainz |
Department: | FB 04 Medizin |
Place: | Mainz |
ROR: | https://ror.org/023b0x485 |
DOI: | http://doi.org/10.25358/openscience-8359 |
Version: | Published version |
Publication type: | Zeitschriftenaufsatz |
License: | CC BY |
Information on rights of use: | https://creativecommons.org/licenses/by/4.0/ |
Journal: | Allergo journal international 31 |
Pages or article number: | 243 250 |
Publisher: | Springer Nature Switzerland AG |
Publisher place: | Cham |
Issue date: | 2022 |
ISSN: | 2197-0378 |
Publisher DOI: | 10.1007/s40629-022-00216-7 |
Appears in collections: | DFG-491381577-H |
Files in This Item:
File | Description | Size | Format | ||
---|---|---|---|---|---|
![]() | olfactory_and_gustatory_disor-20221121100003891.pdf | 297.85 kB | Adobe PDF | View/Open |